Prevent Cancer Foundation welcomes 2025 corporate members advancing cancer prevention and early detection

即時リリース
Audrey Kashatus
703-836-3687
audrey.kashatus@preventcancer.org

Alexandria, Va. – The Prevent Cancer Foundation® proudly welcomes its largest-ever cohort—16 leading companies—as 2025 members of the Corporate Membership Program. These organizations join a growing community dedicated to advancing cancer prevention and early detection nationwide.

“In just two years, our Corporate Membership Program has grown into a thriving community of partners dedicated to cancer prevention and early detection,” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “These corporate partners share our commitment to saving lives, and by collaborating with industry leaders, we’re reaching more people and helping them take charge of their health.”

The 2025 class of corporate members, as of the date of this publication, include:

Silver members

• 正確な科学

• ホロジック

• Ipsen

• ファイザー

• 製薬工業協会

Bronze members

• AstraZeneca

• AVEO Oncology

• アムジェン

• BMS

• エーザイ

• ジェネンテック

• Geneoscopy

• ガーダント

• Lilly

• メルク

• Natera

• サノフィ

Through the Corporate Membership Program, business leaders help expand the Foundation’s reach and impact.  Members participate in Foundation events, including industry roundtables, to collaborate and exchange ideas throughout the year.  Membership supports the Foundation’s work in four key areas: research, education, outreach and advocacy.

The Corporate Membership Program is open to companies who share the Foundation’s vision of a world where cancer is preventable, detectable and beatable for all. To learn more or inquire about joining, contact Jennifer Niyangoda, Vice President of Development and Marketing, at jennifer.niyangoda@preventcancer.org.

###

About the Prevent Cancer Foundation®

The Prevent Cancer Foundation® is the only U.S.-based nonprofit organization solely dedicated to cancer prevention and early detection. Through research, education, outreach and advocacy, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated. We are driven by a vision of a world where cancer is preventable, detectable and beatable for all.

当財団は、2035 年までにがんによる死亡者数を 40% 削減するという課題に立ち向かうべく立ち上がっています。この目標を達成するために、当財団は、がんを早期に発見し、複数のがんのスクリーニングを進めるための革新的な技術に $20 百万ドル、医療サービスが行き届いていないコミュニティへのがんスクリーニングとワクチン接種のアクセス拡大に $10 百万ドル、スクリーニングとワクチン接種の選択肢について一般の人々を啓蒙するために $10 百万ドルを投資することを約束しています。

For more information, please visit www.preventcancer.org.